The first larger scale production campaign of Aptahem’s lead candidate Apta-1 is now ready to start
2020-08-10
Aptahem AB, a leading developer of aptamer-based drugs, announced today that the company is now starting large-scale manufacturing after LGC Bioresearch Technologies Inc. (LGC) completed the Process Development (PD) work enabling larger Pilot scale production campaigns of Apta -1....
Read More